Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.

Chang HH, Liu YL, Lu MY, Jou ST, Yang YL, Lin DT, Lin KH, Tzen KY, Yen RF, Lu CC, Liu CJ, Peng SS, Jeng YM, Huang SF, Lee H, Juan HF, Huang MC, Liao YF, Lee YL, Hsu WM.

Oncotarget. 2017 Jan 17;8(3):4360-4372. doi: 10.18632/oncotarget.13874.

2.

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.

Parikh NS, Howard SC, Chantada G, Israels T, Khattab M, Alcasabas P, Lam CG, Faulkner L, Park JR, London WB, Matthay KK; International Society of Pediatric Oncology.

Pediatr Blood Cancer. 2015 Aug;62(8):1305-16. doi: 10.1002/pbc.25501. Epub 2015 Mar 21.

3.

Treatment of high-risk neuroblastoma.

Sung KW.

Korean J Pediatr. 2012 Apr;55(4):115-20. doi: 10.3345/kjp.2012.55.4.115. Epub 2012 Apr 30.

4.

Anti-GD2 Strategy in the Treatment of Neuroblastoma.

Yang RK, Sondel PM.

Drugs Future. 2010;35(8):665.

5.

High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma.

Carr-Wilkinson J, O'Toole K, Wood KM, Challen CC, Baker AG, Board JR, Evans L, Cole M, Cheung NK, Boos J, Köhler G, Leuschner I, Pearson AD, Lunec J, Tweddle DA.

Clin Cancer Res. 2010 Feb 15;16(4):1108-18. doi: 10.1158/1078-0432.CCR-09-1865. Epub 2010 Feb 9.

6.

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma.

Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, Alaminos M, Rios J, Gerald WL, Kushner B, LaQuaglia M, Mora J.

BMC Cancer. 2009 Feb 3;9:44. doi: 10.1186/1471-2407-9-44.

7.

Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.

Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC, Cheung NK.

Pediatr Blood Cancer. 2009 Jul;53(1):17-22. doi: 10.1002/pbc.21931.

8.

Management and outcome of stage 3 neuroblastoma.

Modak S, Kushner BH, LaQuaglia MP, Kramer K, Cheung NK.

Eur J Cancer. 2009 Jan;45(1):90-8. doi: 10.1016/j.ejca.2008.09.016. Epub 2008 Nov 6.

9.

PPARgamma in Neuroblastoma.

Peri A, Cellai I, Benvenuti S, Luciani P, Baglioni S, Serio M.

PPAR Res. 2008;2008:917815. doi: 10.1155/2008/917815.

10.

Genetic heterogeneity and clonal evolution in neuroblastoma.

Mora J, Cheung NK, Gerald WL.

Br J Cancer. 2001 Jul 20;85(2):182-9.

11.

Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

Mora J, Cheung NK, Kushner BH, LaQuaglia MP, Kramer K, Fazzari M, Heller G, Chen L, Gerald WL.

J Mol Diagn. 2000 Feb;2(1):37-46. Review.

Supplemental Content

Support Center